Antisense Therapeutics (ASX:ANP) share price tumbles 8% amid capital raise

The company’s shares are set to finish the week lower…

| More on:
A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.

Image source: Getty Images

Shares in Antisense Therapeutics Limited (ASX: ANP) are tumbling today following a heavily oversubscribed placement.

At the time of writing, the Antisense share price is trading at 22 cents, down 8.33%. This means that its shares have now fallen more than 20% in the past week alone.

What’s driving Antisense shares lower?

A catalyst for today’s fall in Antisense shares is that investors may be concerned about an impending share dilution.

According to its release, Antisense advised that both institutional and sophisticated investors took part in the placement. The firm commitments received will raise $20 million for the company through the issuance of around 83.33 million ordinary shares.

The offer price will be listed at 24 cents apiece and includes one free attaching unlisted option with every 2 shares subscribed. The strike price of the exercisable option will be at a price of 48 cents for each share applied. These options will have an expiry date on the earlier of either 20 December 2024 or 20 business days after the acceleration trigger date.

The board noted that many of the company’s shareholders did not have the opportunity to participate in the offer. As such, an entitlement offer has been put forward which will enable eligible shareholders to apply for 1 new share for every 9.4 existing shares owned.

The issue price is also listed at 24 cents per new share whilst also receiving one free unlisted option for every 2 new shares issued. This is expected to raise an additional $16.8 million for the company.

Funds collected from the placement will be allocated towards covering a number of costs for the ATL1102 Phase IIb/III clinical study. The clinical trial will run for 52-weeks and will be assessed for muscle strength among a number of participants.

About the Antisense share price

It’s been a wild ride for Antisense shareholders, with the company’s shares accelerating by almost 80% year to date. Looking at a longer time frame, the Antisense share price is up around 140% since this time last year.

Based on today’s price, Antisense presides a market capitalisation of around $137.87 million, with approximately 574 million shares outstanding.

Should you invest $1,000 in Antisense right now?

Before you consider Antisense, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Antisense wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Capital Raising

Scientists working on a screen in laboratory
Capital Raising

Interested in the $750m CSL (ASX:CSL) share purchase plan? Here are the details

The much anticipated CSL Limited (ASX: CSL) share purchase plan (SPP) is officially opening today as the company attempts to …

Read more »

Close up of a sad young Caucasian woman reading about Leigh Creek Energy's declining share price on her phone
Capital Raising

Here’s why the Leigh Creek (ASX:LCK) share price is crashing 8% downstream today

The Leigh Creek Energy Ltd (ASX: LCK) share price is one of the worst performers on the ASX this morning. This comes …

Read more »

A healthcare worker wearing a white coat holds his fingers to his mouth looking worried as healthcare stocks like Cochlear crash today
Mergers & Acquisitions

CSL (ASX:CSL) share price down 8% after raising US$4.5bn

The CSL Limited (ASX: CSL) share price has returned from its trading halt on Thursday morning. At the time of …

Read more »

a man peers out from a high collared jacket with just his eyes and nose visible amid a swirling snowstorm.
Capital Raising

Why is the Queensland Pacific Metals (ASX:QPM) share price in limbo today?

The Queensland Pacific Metals Ltd (ASX: QPM) share price has been put in the freezer today as the company prepares …

Read more »

Iluka share price 3D white rocket and black arrows pointing upwards
Capital Raising

Johns Lyng (ASX:JLG) shares surge 19% out of trading halt. Here’s why

Johns Lyng Group Ltd (ASX: JLG) shares are rocketing in early afternoon trade, up 19% to $8.52 per share. This …

Read more »

Douugh investor looking angry while talking on phone and looking at computer
Capital Raising

The Douugh (ASX:DOU) share price is sinking 9% on Friday. Here’s why

The Douugh Ltd (ASX: DOU) share price is nosediving during Friday afternoon. This comes after the financial wellness app provider released its …

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Capital Raising

Why the Ironbark Zinc (ASX:IBG) share price is rocketing 23% today

The Ironbark Zinc Limited (ASX: IBG) share price has reached a multi-year high after the stock exited its trading halt. This comes …

Read more »

Man in yellow hard hat looks through binoculars as man in white hard hat stands behind him and points.
Mergers & Acquisitions

Johns Lyng (ASX:JLG) share price in focus amid capital raise and major US acquisition

The Johns Lyng Group Ltd (ASX: JLG) share price is still in the freezer as the company undergoes a $230 …

Read more »